Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture
- 31 December 1983
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 21, 259-270
- https://doi.org/10.1016/0065-2571(83)90018-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Inhibition of thymidylate synthase by hydroxyurea in rapidly proliferating P815 mastocytoma cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1982
- Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapyAdvances in Enzyme Regulation, 1981
- Dynamics of modulation of biochemical programs in cancer cellsAdvances in Enzyme Regulation, 1981
- Effect of iron-chelating agents on inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1981
- Role of ribonucleotide reductase in expression of the neoplastic programLife Sciences, 1981
- Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency diseaseCell, 1978
- Specificity of adenosine deaminase inhibitorsBiochemical Pharmacology, 1977
- Components and control of ribonucleotide reductase system of the ratAdvances in Enzyme Regulation, 1977